Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study |
Metastatic Castration-Resistant Prostate Cancer | Phase1 | Germany Netherlands Spain Switzerland United Kingdom United States View all |
NCT06531499 |
Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
Idiopathic Inflammatory Myopathies | Phase2 | France Germany Israel Italy Japan Netherlands Saudi Arabia Singapore Spain Switzerland Taiwan United Kingdom United States View all |
NCT06665256 |
Specified Drug-use Surveillance of Fabhalta Capsules |
Paroxysmal Nocturnal Hemoglobinuria | Japan | NCT06606314 | |
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) |
Healthy Volunteers, Pulmonary Arterial Hypertension | Phase1, Phase2 | Australia Brazil Czechia Germany Greece Italy Latvia Portugal Romania Spain United Kingdom United States View all |
NCT06649110 |
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). |
Systemic Lupus Erythematosus, SLE | Phase1 | China Germany Hungary Netherlands Spain Switzerland View all |
NCT06335979 |
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) |
Sickle Cell Disease | Phase3 | Brazil Colombia Kenya Uganda United States View all |
NCT06439082 |
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) |
Spinal Muscular Atrophy (SMA) | Greece Ireland Israel Poland Portugal Romania Russia South Korea Taiwan United States View all |
NCT04174157 | |
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma |
Asthma | Phase3 | Argentina Austria Bulgaria Colombia Czechia Greece Guatemala Hungary Italy Mexico Panama Portugal Romania South Africa Spain Vietnam View all |
NCT05562466 |
Home Reported Outcomes in PNH |
Paroxysmal Nocturnal Hemoglobinuria | United States | NCT06411626 | |
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis |
Diffuse Cutaneous Systemic Sclerosis | Phase2 | Argentina Austria Belgium Brazil China Colombia France Germany Greece Hungary India Italy Japan Malaysia Mexico Poland Portugal South Korea Spain Taiwan Thailand Turkey (Türkiye) United Kingdom United States Vietnam View all |
NCT06470048 |